Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction

Understanding the distinct pathogenic mechanisms that culminate in allograft fibrosis and chronic graft failure is key in improving outcomes after solid organ transplantation. Here, we describe an F1 → parent orthotopic lung transplant model of restrictive allograft syndrome (RAS), a particularly fu...

Full description

Bibliographic Details
Main Authors: Keizo Misumi, David S. Wheeler, Yoshiro Aoki, Michael P. Combs, Russell R. Braeuer, Ryuji Higashikubo, Wenjun Li, Daniel Kreisel, Ragini Vittal, Jeffrey Myers, Amir Lagstein, Natalie M. Walker, Carol F. Farver, Vibha N. Lama
Format: Article
Language:English
Published: American Society for Clinical investigation 2020-12-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.136533
_version_ 1819111286964748288
author Keizo Misumi
David S. Wheeler
Yoshiro Aoki
Michael P. Combs
Russell R. Braeuer
Ryuji Higashikubo
Wenjun Li
Daniel Kreisel
Ragini Vittal
Jeffrey Myers
Amir Lagstein
Natalie M. Walker
Carol F. Farver
Vibha N. Lama
author_facet Keizo Misumi
David S. Wheeler
Yoshiro Aoki
Michael P. Combs
Russell R. Braeuer
Ryuji Higashikubo
Wenjun Li
Daniel Kreisel
Ragini Vittal
Jeffrey Myers
Amir Lagstein
Natalie M. Walker
Carol F. Farver
Vibha N. Lama
author_sort Keizo Misumi
collection DOAJ
description Understanding the distinct pathogenic mechanisms that culminate in allograft fibrosis and chronic graft failure is key in improving outcomes after solid organ transplantation. Here, we describe an F1 → parent orthotopic lung transplant model of restrictive allograft syndrome (RAS), a particularly fulminant form of chronic lung allograft dysfunction (CLAD), and identify a requisite pathogenic role for humoral immune responses in development of RAS. B6D2F1/J (H2-b/d) donor lungs transplanted into the parent C57BL/6J (H2-b) recipients demonstrated a spectrum of histopathologic changes, ranging from lymphocytic infiltration, fibrinous exudates, and endothelialitis to peribronchial and pleuroparenchymal fibrosis, similar to those noted in the human RAS lungs. Gene expression profiling revealed differential humoral immune cell activation as a key feature of the RAS murine model, with significant B cell and plasma cell infiltration noted in the RAS lung allografts. B6D2F1/J lung allografts transplanted into μMt–/– (mature B cell deficient) or activation-induced cytidine deaminase (AID)/secretory μ-chain (μs) double-KO (AID−/−μs−/−) C57BL/6J mice demonstrated significantly decreased allograft fibrosis, indicating a key role for antibody secretion by B cells in mediating RAS pathology. Our study suggests that skewing of immune responses determines the diverse allograft remodeling patterns and highlights the need to develop targeted therapies for specific CLAD phenotypes.
first_indexed 2024-12-22T03:55:13Z
format Article
id doaj.art-23cc3c55a9cf486dad2c4230b7195d23
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-12-22T03:55:13Z
publishDate 2020-12-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-23cc3c55a9cf486dad2c4230b7195d232022-12-21T18:39:54ZengAmerican Society for Clinical investigationJCI Insight2379-37082020-12-01523Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunctionKeizo MisumiDavid S. WheelerYoshiro AokiMichael P. CombsRussell R. BraeuerRyuji HigashikuboWenjun LiDaniel KreiselRagini VittalJeffrey MyersAmir LagsteinNatalie M. WalkerCarol F. FarverVibha N. LamaUnderstanding the distinct pathogenic mechanisms that culminate in allograft fibrosis and chronic graft failure is key in improving outcomes after solid organ transplantation. Here, we describe an F1 → parent orthotopic lung transplant model of restrictive allograft syndrome (RAS), a particularly fulminant form of chronic lung allograft dysfunction (CLAD), and identify a requisite pathogenic role for humoral immune responses in development of RAS. B6D2F1/J (H2-b/d) donor lungs transplanted into the parent C57BL/6J (H2-b) recipients demonstrated a spectrum of histopathologic changes, ranging from lymphocytic infiltration, fibrinous exudates, and endothelialitis to peribronchial and pleuroparenchymal fibrosis, similar to those noted in the human RAS lungs. Gene expression profiling revealed differential humoral immune cell activation as a key feature of the RAS murine model, with significant B cell and plasma cell infiltration noted in the RAS lung allografts. B6D2F1/J lung allografts transplanted into μMt–/– (mature B cell deficient) or activation-induced cytidine deaminase (AID)/secretory μ-chain (μs) double-KO (AID−/−μs−/−) C57BL/6J mice demonstrated significantly decreased allograft fibrosis, indicating a key role for antibody secretion by B cells in mediating RAS pathology. Our study suggests that skewing of immune responses determines the diverse allograft remodeling patterns and highlights the need to develop targeted therapies for specific CLAD phenotypes.https://doi.org/10.1172/jci.insight.136533PulmonologyTransplantation
spellingShingle Keizo Misumi
David S. Wheeler
Yoshiro Aoki
Michael P. Combs
Russell R. Braeuer
Ryuji Higashikubo
Wenjun Li
Daniel Kreisel
Ragini Vittal
Jeffrey Myers
Amir Lagstein
Natalie M. Walker
Carol F. Farver
Vibha N. Lama
Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
JCI Insight
Pulmonology
Transplantation
title Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
title_full Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
title_fullStr Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
title_full_unstemmed Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
title_short Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
title_sort humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
topic Pulmonology
Transplantation
url https://doi.org/10.1172/jci.insight.136533
work_keys_str_mv AT keizomisumi humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT davidswheeler humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT yoshiroaoki humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT michaelpcombs humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT russellrbraeuer humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT ryujihigashikubo humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT wenjunli humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT danielkreisel humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT raginivittal humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT jeffreymyers humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT amirlagstein humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT nataliemwalker humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT carolffarver humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction
AT vibhanlama humoralimmuneresponsesmediatethedevelopmentofarestrictivephenotypeofchroniclungallograftdysfunction